RNAC

6.1404.24%
BT

Blaine T. Davis

Chief Financial Officer

Mr. Blaine T. Davis serves as Chief Financial Officer of Cartesian Therapeutics, Inc. since November 28, 2022. He served as Chief Financial Officer of Selecta Biosciences, Inc. from November 28, 2022. He had been Chief Financial Officer at Protara Therapeutics, Inc. (formerly known as ArTara Therapeutics, Inc.). since February 11, 2020 until July 15, 2022 and served as its Secretary. Mr. Davis served as Vice President and Head of Investor Relations and Corporate Communications of Insmed Incorporated since July 2017 until January 2020. Mr. Davis was Senior Vice President and General Manager of Specialty Pharmaceuticals at Endo International plc since January 2015. Mr. Davis served as Managing Director at Endo Netherlands B.V. Mr. Davis served as Senior Vice President of Corporate Affairs at Endo International plc until January 2015 and also served as its President of Endo Ventures until January 2015. Mr. Davis served as Vice President of Investor Relations & Corporate Communications of Endo since May 2008. Mr. Davis served as Investor Relations Executive of Bristol-Myers Squibb Sarl. Mr. Davis served as Director of Investor Relations of Bristol-Myers Squibb Sarl since January 2005, where he managed Bits communication with the investment community as well as advised senior management on capital markets dynamics. Mr. Davis served as Director of Alliance Management with in the Corporate and Business Development unit at Bristol-Myers Squibb, where he was responsible for the overall management of Bristol-Myers Squibb/AstraZeneca collaboration in diabetes. Prior to 2005, Mr. Davis served as Vice President/Sector Head in the Corporate Advisory Services Group at Thomson Financial, where he led a team working primarily with publicly traded companies in the financial sector. He has experience in investor relations, corporate affairs and sales and marketing at life sciences companies focused on rare diseases. Mr. Davis held multiple executive leadership positions at Endo International plc from May 2008, including senior vice president and General Manager, specialty pharmaceuticals; and Senior Vice President of Investor Relations and Corporate Communications. Mr. Davis graduated holds a Bachelor of Arts in biology and psychology with a minor in economics from Middlebury College in Middlebury, Vermont.

Positions